Ian Michael Estepan - 11 Mar 2026 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Reporting relationship: Chief Operating Officer
Issuer ticker: SRPT
Reported as of: 11 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Mar 2026, 20:09:03 UTC
Prior SEC filing: 11 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan

Key filing fact

Ian Michael Estepan filed Form 4 for Sarepta Therapeutics, Inc. (SRPT) on 13 Mar 2026.

Key facts

This page summarizes Ian Michael Estepan's Form 4 filing for Sarepta Therapeutics, Inc. (SRPT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Mar 2026, 20:09.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001836254 Primary reporting owner

Relationship: Chief Operating Officer
Address: 215 FIRST STREET, SUITE 415, CAMBRIDGE
Signature: /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan
Signature date: 13 Mar 2026

Shares, units, or other non-derivative securities reported in this filing.

SRPT transaction

Tax liability

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025.